Maginificent 7 - First Inductees into MML
Whilst the global pandemic of COVID-19 stunted most non-core medical technology development, Capital Kinetics have recruited the inaugural Super 7 to assist in moving healthcare forward. The first of the MedTech Makers Lab (MML) mentee technologies will launch in the United Kingdom in 2022.
Five companies have been recruited from abroad in Latvia, Poland, Israel, India and the United State of America. These alongside two home-grown companies from England and Wales round off the first matriculating class of 2022.
Focusing on diabetes, breast cancer, fertility, orthopaedics, and cardiology, these companies will be working with MML to develop a pathway for clinical validation and funding. The goal is for these companies to ultimately become onboarded as treatment programs in the UK’s National Health Service (NHS) and other healthcare providers around the world have been impacted heavily by the pandemic.
Christian Kumar, Founder and CEO of Capital Kinetics has said "The impact of COVID-19 has delayed thousands of procedures each month, the backlog of non-essential treatment will impact the NHS for years to come. Our mission is to introduce the latest technology to speed up diagnostics, reduce waiting times and impact the overall cost of delivery".
Register HERE to keep up to date with the developments from the Lab and learn more about our Super 7 inductees.